EASL Clinical Practice Guidelines on the management of cystic liver diseases

J Hepatol. 2022 Oct;77(4):1083-1108. doi: 10.1016/j.jhep.2022.06.002. Epub 2022 Jun 18.

Abstract

The advent of enhanced radiological imaging techniques has facilitated the diagnosis of cystic liver lesions. Concomitantly, the evidence base supporting the management of these diseases has matured over the last decades. As a result, comprehensive clinical guidance on the subject matter is warranted. These Clinical Practice Guidelines cover the diagnosis and management of hepatic cysts, mucinous cystic neoplasms of the liver, biliary hamartomas, polycystic liver disease, Caroli disease, Caroli syndrome, biliary hamartomas and peribiliary cysts. On the basis of in-depth review of the relevant literature we provide recommendations to navigate clinical dilemmas followed by supporting text. The recommendations are graded according to the Oxford Centre for Evidence-Based Medicine system and categorised as 'weak' or 'strong'. We aim to provide the best available evidence to aid the clinical decision-making process in the management of patients with cystic liver disease.

Publication types

  • Practice Guideline

MeSH terms

  • Cysts* / diagnosis
  • Cysts* / therapy
  • Hamartoma*
  • Humans
  • Liver Diseases* / diagnosis
  • Liver Diseases* / therapy

Supplementary concepts

  • Polycystic liver disease